Addex Therapeutics (ADXN) vs XTL Biopharmaceuticals (XTLB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($5.3 million vs $4.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADXN | XTLB |
|---|---|---|
| Share price | $3.00 | $1.99 |
| Market cap | $5.26M | $4.89M |
| 1-day change | +0.76% | +0.51% |
| EPS (TTM) | $-7.56 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $7.44 |
| 52-week low | $2.56 | $1.97 |
| Distance from 52-week high | -74.94% | -73.25% |
| Average volume | 138.01K | 8.49K |
| Shares outstanding | 1.75M | 2.46M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ADXN vs XTLB FAQ
Which is bigger, Addex Therapeutics or XTL Biopharmaceuticals?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $5.26M compared with $4.89M for XTL Biopharmaceuticals (XTLB).
Are Addex Therapeutics and XTL Biopharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.